Objective-To determine whether paraoxonases (PONs) are expressed in macrophages and to analyze the oxidative stress effect on their expression and activities. Methods and Results-We demonstrated the presence (mRNA, protein, activity) of PON2 and PON3 but not PON1 in murine macrophages, whereas in human macrophages, only PON2 was expressed. Under oxidative stress as present in mouse peritoneal macrophages (MPMs) from apoE-deficient (E 0 ) mice as well as in C57BL6 mice, MPMs that were incubated with buthionine sulfoximine, with angiotensin II, with 7-ketocholesterol, or with oxidized phosphatidylcholine, PON2 mRNA levels and lactonase activity toward dihydrocoumarin significantly increased (by 50% to 130%). In contrast, PON3 lactonase activity toward lovastatin was markedly reduced (by 29% to 57%) compared with control cells. The supplementation of E 0 mice with dietary antioxidants (vitamin E, pomegranate juice) significantly increased macrophage PON3 activity (by 23% to 40%), suggesting that oxidative stress was the cause for the reduced macrophage PON3 activity. Incubation of purified PON2 or PON3 with E 0 mice MPMs resulted in reduced cellular lipid peroxides content by 14% to 19% and inhibition of cell-mediated LDL oxidation by 32% to 39%.
P araoxonases (PONs) 1, 2, and 3 are members of a multigene family. 1 These genes share 65% identity at the amino acid level, but all PON2 and PON3 cDNAs sequenced to date lack the three nucleotides residues of codon 106, which are present in PON1. [1] [2] [3] PON1 is an esterase associated in serum with HDL. 4 Recent studies in PON1 knockout mice 5 and PON1 overexpressing mice 6 revealed that PON1 acts as an antiatherogenic agent. In vitro studies demonstrate that PON1 protects against oxidative stress 7-10 by hydrolyzing specific oxidized lipids in lipoproteins, 7, 8 macrophages, 9 and atherosclerotic lesions. 10 Human and rabbit PON3 are also HDL associated 11, 12 and rabbit PON3 is more efficient than rabbit PON1 in protecting LDL against oxidation. 12 Under oxidative stress, which is associated with enhanced atherosclerosis, 13 PON1 is inactivated, 14, 15 and antioxidants preserve its activity. 14 Serum PON1 levels and activities are lower in patients with cardiovascular heart disease compared with healthy subjects 16 -18 and also in rabbits and mice fed an atherogenic diet. 19, 20 PON1 and PON3 mRNA are predominantly expressed in liver, whereas PON2 mRNA is found in different tissues, 21 including human endothelial and aortic smooth muscle cells, 22 but its presence in macrophages has not been analyzed. PON2 protein is not detectable in HDL 22 and, therefore, was thought to function within cells. PON2 overexpression in HeLa cells was shown to lower intracellular oxidative state and these cells were less able to oxidize LDL. 22 PON2 and PON3 can modulate oxidative stress, but it is unknown whether these proteins are inactivated when cells are oxidatively stressed or whether expression levels are regulated in response to PON inactivation. Macrophages may be a model to address these questions because they play a key role in early atherogenesis, 23, 24 and under oxidative stress their lipids are oxidized. [25] [26] [27] These "oxidized macrophages" possess increased capability to oxidize LDL 25, 27 and to take up oxidized LDL, 9 leading to foam cell formation.
The aim of the present study was to determine the expression profile and activities of PONs in macrophages, and to analyze the effect of oxidative stress on macrophage PON expression and activities.
Methods

Mouse Studies
ApoE-deficient (E 0 ) mice, which are hypercholesterolemic under oxidative stress and develop accelerated atherosclerosis, 28, 29 were compared with age-and gender-matched controls (C57BL6 mice). All mice received a chow diet. For the vitamin E and pomegranate juice (PJ) consumption experiments, 12 female 5-week-old E 0 mice were equally distributed into 3 groups. Two groups received either vitamin E (40 mg/kg/day) or PJ (0.3 mol polyphenols/kg/day) in their drinking water for 2 months. The placebo group received only water.
Cells J774 A.1 Macrophage-Like Cell Line
J774 A.1 cells were obtained from ATCC (Rockville, MD) and maintained in DMEM containing 5% FCS, penicillin (100 U/mL), streptomycin (100 g/mL), and glutamine (2 mmol/L), that is, supplemented DMEM.
Mouse Peritoneal Macrophages (MPMs)
MPMs were harvested 4 days after intraperitoneal injection of thioglycolate. 27 The cells (2ϫ10 7 /mouse) were washed with PBS at 1000g for 10 minutes, diluted to 10 6 /mL in supplemented DMEM, plated, and incubated (5% CO 2 , 95% air) at 37°C. After 2 hours, nonadherent cells were removed, and the monolayer was further incubated.
Isolation of E 0 Mice Arterial Macrophages
E 0 mice were sacrificed and their entire aortas were removed and placed in Hanks' balanced salt solution. The macrophage fraction was separated by discontinuous density gradient of metrizamide. 30
Human Monocyte-Derived Macrophages (HMDMs)
HMDMs were separated from blood of healthy volunteers. 31 The cells were plated at 10 6 /mL in RPMI medium containing 10% FCS. After 2 hours of incubation at 37°C, nonadherent cells were removed, and RPMI containing 10% autologous serum was added. Macrophages were used 8 days after plating.
Preparation of Cell Lysate and Cell Fractionation
Cell Lysate
Cells (2ϫ10 7 ) were washed scraped into PBS and pelleted (1000g for 10 minutes at 4°C). Pellets were suspended in 0.5 mL of RIPA buffer (1ϫ PBS, 1% Igepal, 0.5% sodium deoxycolate, 0.1% sodium dodecyl sulfate, 1 mmol/L phenylmethyl sulfonyl fluoride [PMSF], and 100 mol/L leupeptin).
Cell Fractionation
Membrane (microsomal) and cytosol fractions were prepared, 32 and membranes were suspended to 10 9 cell equivalents/mL in RIPA buffer. Aliquots were removed from cell lysates, membrane, and cytosol fractions for protein determination. 33
Preparation of Oxidized L-␣-1-Arachidonyl-2-Palmitoyl-Phosphatidylcholine (Ox-PAPC)
PAPC (5 mg) was dissolved in 1 mL of 10 mmol/L Tris buffer (pH 7.4) to form multilamellar liposomes. The PAPC liposomes were oxidized by incubation for 4 hour at 37°C under oxygen stream. The extent of PAPC oxidation was measured by the thiobarbituric acid reactive substances (TBARS) and the lipid peroxides assays. 26, 34 Ox-PAPC contained 275 nmol of MDA equivalents/mL and 1770 nmol lipid peroxides/mL, respectively.
Macrophage Lipid Peroxides
MPMs (2ϫ10 6 ) were washed with PBS and lipid extracted with hexane:isopropanol (3:2, v:v). The hexane phase was evaporated under nitrogen, and the amount of lipid peroxides was determined. 26 NaOH (0.1N) was added to the cells for protein determination. 33 
Macrophage PON Activities Measurements
Cells (2ϫ10 7 ) were washed, scraped into Tris buffer (25 mmol/L Tris/HCL, pH 7.6, 1 mmol/L CaCl 2 ), and pelleted (1000g for 10 minutes at 4°C). The pellets were resuspended with 2 mL of Tris buffer and sonicated for 2ϫ20 seconds at 80w on ice, and the protein concentration was determined. 33 Enzyme activities were measured using 200 L of sonicate (200 to 300 g protein) per mL assay mixture. PON and lactonase activities were measured using paraoxon and DHC as substrates, respectively. 12, 35 The absorbance was monitored at 0 and 5 minutes after substrates addition. Lactonase activity using LST was determined by high-performance liquid chromatography after cell sonicates incubation with LST for 4 hours. 12 Measurements were as follows: 1 U of PON activityϭ1 nmol of paraoxon hydrolyzed/minute and 1 U of lactonase activityϭ 1 mol of DHC hydrolyzed/minute or 1 pmol of LST hydrolyzed/minute.
Purification of PON1, PON2, and PON3
Human PON2 (hPON2) was purified from HEK293 cells stably transfected with hPON2 cDNA, and its identity was confirmed at the Protein Sequencing Core, University of Michigan, (Ann Arbor, Mich). hPON1 and rabbit PON3 (rPON3) were purified as previously described. 10, 12 
Macrophage PONs Protein Assay
Western blot analysis was performed as previously described. 11 The primary antibody was rabbit antihuman PON2 diluted (1:1000, v/v). This antibody is polyclonal and was raised against PON2-specific peptide H-LKEEKPRARELRISRGFDLA by Research Genetics, Inc, (Huntsville, Ala). This antibody cross-reacts also with rPON3 and with mouse peptides of the expected molecular size of PON2 and PON3 but not with human PON1. The secondary antibody was horseradish peroxidase-conjugated antirabbit IgG, diluted 1:4000 v/v. The membranes were developed using the ECL Western blotting kit (Amersham). Purified hPON1, hPON2 and rPON3 were used as positive controls.
PON2 and PON3 mRNA Expression by Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
Total RNA was extracted from macrophages with Tri-reagent. cDNA was generated from 1 g of total RNA using RT and an oligo DT primer. RT products were subjected to PCR amplification using gene specific primers (Life Technologies).
The PCR program used for mouse and human PONs was as follows: 1 minute at 94°C, 30 cycles for PON3 and GAPDH, or 40 cycles for PON1 and PON2 (30 seconds at 94°C, 30 seconds at 57°C, 1 minute at 68°C), and 7 minutes at 68°C. The cDNA products were separated on 1% agarose gel containing ethidium bromide.
Macrophage-Mediated LDL Oxidation
Human LDL was isolated from plasma of normolipidemic subjects. 36 MPMs (2ϫ10 6 ) were incubated with LDL (100 g of protein/mL) in the presence of 5 mol/L CuSO 4 for 5h at 37°C. Cell-mediated oxidation of LDL was then determined by the TBARS assay. 34 
Statistical Analysis
Statistical analysis was performed using the Mann-Whitney test in comparing means from 3 to 4 experiments, whereas ANOVA was used when more than 2 groups were compared. Results represent meanϮSD
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Results
PON 2 and PON3 But Not PON 1 Are Expressed in Macrophages
RT-PCR analysis revealed PON2 and PON3 mRNA in several types of macrophages, including MPMs from Balb C mice, J-774 A.1 murine macrophage-like cell line, and arterial macrophages derived from E 0 mice aortas ( Figure  1A ). The MPM cDNA bands were confirmed as mouse PON2 and PON3 by sequencing. Analysis of HMDMs demonstrated expression of PON2 but not PON3 mRNA ( Figure 1A ). PON1 mRNA was not detected in either mouse or human macrophages (data not shown). Western blot analysis ( Figure 1B ) was performed using rabbit antihuman PON2 antibody or rabbit preimmune serum. The antibody reacted with purified hPON2 and rPON3 but not with hPON1 and detected bands of mouse peptides of the expected molecular size of PON2 and PON3 in lysate of MPMs and J774 A.1. Furthermore, we demonstrated that PON2 and PON3 were located in microsomes but not in cytosol of murine macrophages. In lysate from HMDMs, however, only a PON2 protein band was observed. All samples that reacted with the antihuman PON2 antibody (except for hPON1 and MPM lysate) were analyzed in the gel that was incubated with the preimmune serum. In this gel, no bands could be detected, indicating the antibody specificity. PON2 and PON3 protein expression correlates with the mRNA expression pattern.
To determine whether macrophage PON2 and PON3 proteins were functional, we measured the enzymatic activities of known PONs in MPM sonicate with the following substrates: paraoxon, DHC, and LST. No PON activity (PON1 specific) was detected, in accordance with the lack of PON1 mRNA in these macrophages. Lactonase activity with LST could be attributed to PON3, whereas DHC hydrolysis is catalyzed by both PON2 and PON3. The purified hPON2 and rPON3 preparations used in this study had lactonase activity (DHC) of 49 U/mL or 114U/mL, respectively, but only rPON3 hydrolyzed 79% of LST (5 g/mL) after 4 hours of incubation. Lactonase activity (DHC) was found in both HMDMs and MPMs (0.110Ϯ0.008 versus 0.090Ϯ0.017 U/mg cell protein). In contrast, only MPM hydrolyzed LST (85.5Ϯ3.5 U/mg cell protein), whereas in HMDM this activity was absent, suggesting that in human macrophages only PON2 activity is present.
Lactone hydrolysis could be catalyzed also by carboxylesterases. To demonstrate that macrophage lactonase activities with DHC and LST are specific for the respected PONs, we used EDTA to chelate calcium ions (required for the enzymatic activities of PONs) and PMSF (to inhibit the carboxyesterases). The addition of EDTA (10 mmol/L) but not of PMSF (2 mmol/L) to MPM sonicate resulted in a marked inhibition (90%) of the lactonase activity with DHC (from 0.090Ϯ0.017 to 0.009Ϯ0.001 U/mg cell protein) and a 77% inhibition of lactonase activity with LST (from 85.5Ϯ3.5 to 19.7Ϯ2.1 U/mg cell protein). Furthermore, on incubation of MPM sonicate for 2 hours at 25°C with the antihuman PON2 antibody (diluted 1:500) PON3 lactonase activity (LST) was reduced by 52% (from 85.5Ϯ3.5 to 41Ϯ2 U/mg cell protein), and PON2ϩPON3 lactonase activity (DHC) was reduced by 63% (from 0.090Ϯ0.017 to 0.034Ϯ0.005 U/mg cell protein), indicating that these activities could be attributed to PONs and not to other enzymes.
PON2 and PON3 mRNA Levels and Activities in E 0 Mice Macrophages: Ex Vivo Studies
During atherosclerosis progression in E 0 mice, increased oxidative stress in serum and macrophages has been demonstrated. 26 -28 To examine whether oxidative stress affected macrophage PON2 and PON3 expression and activities, we isolated MPM from 2-and 4-month-old E 0 mice. In 2-monthold E 0 mice MPMs, PON2 mRNA levels were increased (Ϸ1.5 fold) compared with control (C57BL6) mice MPMs (Figure 2A) , whereas PON3 mRNA levels were similar ( Figure 2B ) in both strains. By 4 and 7 months of age, PON2 mRNA levels in E 0 mice MPMs were further increased (Ϸ2 fold) compared with the levels at 2 months (Figure 2A) , whereas macrophage PON3 mRNA levels did not change ( Figure 2B ). In MPMs from control mice at the age of 2, 4, and 7 months, similar levels of PON2 and PON3 mRNA were found (data not shown). These results suggest that oxidative stress markedly increases PON2 mRNA levels but has no effect on PON3 mRNA levels.
PON3 lactonase activity (LST) in 2-and 4-month-old E 0 mice MPMs was reduced by 18% and 52%, respectively, compared with control mice MPMs at the same age (Table 1) . In contrast, MPM (PON2ϩPON3) lactonase activity with DHC was similar in both E 0 and control mice at 2 months of age (Table 1) but was increased by 60% in E 0 MPMs at 4 months of age (Table 1 ). The reduction in macrophage PON3 activity was not the result of PON3 secretion because no lactonase activity (LST) could be detected in the medium obtained from E 0 MPM.
To test if the reduction of PON3 lactonase activity in E 0 macrophages is caused by oxidative stress, 6-week-old E 0 mice were supplemented for 2 months with PJ (0.3 mol of total polyphenols/kg/d), or vitamin E (40 mg/kg/d), which have been shown previously to reduce macrophage oxidative stress and atherosclerosis in E 0 mice. 37, 38 Both PJ and vitamin E consumption by E 0 mice decreased MPM lipid peroxides content by 37% and 33%, respectively, (from 40Ϯ2 to 25.2Ϯ3.0 and 26.8Ϯ3.0 nmol/mg cell protein, respectively). MPM PON3 lactonase activity (LST) was increased by 23% or 26% on PJ and vitamin E supplementation (from 47.0Ϯ2.5 to 57.9Ϯ1.2 and 59.1Ϯ1.7 U/mg cell protein, respectively), indicating that PON3 inactivation in E 0 mice MPM was caused by oxidative stress. Lactonase activity (DHC) in the placebo group and in the supplemented mice was similar (data not shown), which might be the result of reduced PON2 activity and increased PON3 activity.
Macrophage PON2 and PON3 mRNA Levels and Activities Under Oxidative Stress: In Vitro Studies
To directly assess the effect of oxidative stress on macrophage PON2 and PON3 expression and activities, C57BL6 mice MPMs were incubated with 0.05 mmol/L of buthionine sulfoximine (BSO), a specific inhibitor of glutathione synthesis, 39 or with Angiotensin II (Ang II; 10 Ϫ7 mol/L; Table 2 ). 40 In the BSO-treated cells, reduced glutathione (GSH) content was decreased by 90% (from 10Ϯ2 to 1.0Ϯ0.1 nmol/mg cell protein). Macrophage lipid peroxides content increased on incubation with BSO or Ang II (49% and 39%, respectively). In parallel, BSO-and Ang II-treated macrophages exhibited reduced PON3 lactonase activity (LST, 30% and 41%, respectively). In contrast, lactonase activity (DHC) was markedly increased on macrophage treatment with BSO or with Ang II (52% or 39%, respectively).
To analyze macrophage-oxidized lipids, which could be responsible for the observed changes in PONs activities, we incubated control MPMs with 7-ketocholesterol (7-KETO, 20 mol/L), or with Ox-PAPC (15 g/mL; Table 2 ). This resulted in increased MPM lipid peroxides content (30% and 60%, respectively) and in substantial reduction of PON3 activity (LST, 30% and 27%, respectively). In contrast, incubation with Ox-PAPC or with 7-KETO significantly increased lactonase activity (DHC) by 40% or 14%, respectively, compared with control cells. In all oxidative systems (BSO-, Ang II-, 7-KETO-, and Ox-PAPC-treated macrophages), PON2 mRNA levels were significantly higher (2.3-, 2.0-, 1.9-, and 2-fold, respectively) whereas PON3 mRNA levels were similar compared with untreated control cells ( Table 2 ).
Effect of PON2 and PON3 on Macrophage Oxidative Stress
As oxidative stress selectively affected PON2 (activation) and PON3 (inactivation), we next questioned the abilities of Figure 3A) and inhibited cell-mediated LDL oxidation by 39% and 32%, respectively ( Figure 3B ).
Discussion
Atherosclerosis is associated with oxidized lipids accumulation in arterial macrophages, which affects their atherogenic properties. 9,25,27 PON1 mass was detected in atherosclerotic lesions, 41 PON2 was detected in human endothelial and smooth muscle cells, 22 but no data are available yet on expression of PONs in macrophages and on their possible role in atherogenesis. We hypothesized that macrophages possess PONs and that their expression and activities may be regulated by oxidative stress. Indeed, in the present study we clearly demonstrated for the first time the presence of PONs (mRNA, protein, and enzymatic activities) in macrophages. PON2 and PON3 were found in murine macrophages, whereas, in human macrophages only PON2 was present. No PON1 was found in human and mouse macrophages. In MPMs, both PON2 and PON3 were associated with the membrane fraction. Similarly, PON2 protein was recently shown to be present in the plasma membrane of PON2overexpressing cells. 22 Next, we demonstrated that mouse macrophage PON2 and PON3 expression and activities were affected differently by oxidative stress. We performed ex vivo as well as in vitro studies, which showed that under oxidative stress PON2 expression and enzymatic activity increased, whereas PON3 expression did not change, but PON3 activity decreased. In the ex vivo studies, E 0 mice MPMs had significantly higher PON2 mRNA levels but similar PON3 mRNA levels compared with control C57BL6 mice. In the in vitro studies we induced oxidative stress in macrophages with the GSH synthesis inhibitor BSO or with Ang II, which also resulted in a significant increase of PON2 but not PON3 mRNA levels. Oxidized lipids were shown to reduce hepatic PON1 expression 15 but not PON3 expression in HepG2 cells. 11 In the current study, treatment of MPMs with 7-KETO or Ox-PAPC did not affect PON3 mRNA levels but increased PON2 expression. The increase in PON2 mRNA levels may be the cell response to oxidative stress, as was shown for other cellular antioxidant enzymes. 42 In all systems studied (E 0 MPMs, BSO-, Ang II-, 7-KETO-, and Ox-PAPC-treated cells), we found increased PON2 lactonase activity (with DHC), which could be explained with the increased PON2 expression and/or higher resistance to inactivation. In contrast, PON3 lactonase activity (with LST) decreased in parallel to the extent of the oxidative stress. Oxidized lipids were shown to inactivate both serum and hepatic PON1. 14, 15 In the present study we Results are given as meanϮSD of three different experiments. C57BL6 mice-MPM were incubated for 20 hours at 37°C without (Control) and with 0.05 mmol/L of BSO, with10 Ϫ7 mol/L of Ang II, with 20 mol/L of 7-KETO, or with 15 g/mL of Ox-PAPC. The amount of protein and lipid peroxides, as well as lactonase activities toward DHC or LST were measured in the cell (10 7 /mL) sonicate. Densitometric analysis of PON2 and PON3 mRNA bands intensity was normalized to that of GAPDH. *PϽ0.01 vs Control. demonstrated that PON3 was similarly inactivated in E 0 MPMs or on incubation of macrophages with 7-KETO or with Ox-PAPC. Moreover, antioxidants has been shown to preserve PON1 activity, 14 and we observed similar effect on macrophage PON3 activity after supplementation of E 0 mice with PJ and vitamin E. The physiological role of cellular PON2 and PON3 is not yet known, but recent studies indicate that PON2 and PON3 may act as potent cellular antioxidants. 11, 22 Pretreatment of cultured aortic endothelial cells with supernatants from HeLa cells overexpressing PON3 prevented the formation of mildly oxidized LDL. 11 PON2 overexpression was shown to lower the intracellular oxidative state of HeLa cells treated with hydrogen peroxide or with oxidized phospholipids, 22 and these cells were less able to oxidize LDL. 22 Similarly, in the present study we demonstrated that PON2 and PON3 reduced oxidative stress in macrophages from E 0 mice. It is possible that these enzymes hydrolyze oxidized phospholipids in the macrophage plasma membrane, leading to reduction in cellular lipid peroxides content. PON1 was also shown to reduce the content of macrophage lipid peroxides, and it possesses the capability to hydrolyze cholesteryllinoleate hydroperoxides in oxidized LDL and in atherosclerotic lesions in addition to core aldehydes in oxidized phosphatidylcholine. 7 , 1 0 , 4 3 , 4 4 The antiatherogeneicity of PON1 was recently demonstrated 45 by its capacity to decrease macrophage cholesterol biosynthesis.
All three PONs may act selectively in the arterial wall and in the circulation. PON2 can protect against oxidation in arterial cells, such as endothelial cells, smooth muscle cells, and macrophages. In HMDMs only PON2 is expressed, suggesting that PON2 may be more suited than PON3 to act against macrophage oxidative stress. As for PON3, its absence in human macrophages suggests that in humans (but not in mice) it may act (like PON1) only in the circulation.
In the present study we have demonstrated for the first time the presence of PON2 and PON3 in mouse macrophages. Under oxidative stress, macrophage PON2 but not PON3 mRNA levels and activity significantly increased, whereas PON3 activity was significantly reduced. The exact role of cellular PONs in macrophage foam cell formation under oxidative stress during the development of atherosclerosis may be further elucidated by the use of PON2 and PON3 transgenic knockout and knockin animal models, as well as by studies of PON2 and PON3 transfected cells.
